Cerebral palsy, new therapeutic possibilities;Paralisia cerebral, novas perspectivas terapêuticas

Jornal de Pediatria

Volumn 78, Issue SUPPL. 1, 2002, Pages

  Rotta, Newra Tellechea ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b NONE   (Brazil)

Author keywords

Cerebral palsy; Neurology; Pediatrics; Spasticity

Indexed keywords

BACLOFEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CLONIDINE; DANTROLENE; DIAZEPAM; LAMOTRIGINE; ORPHENADRINE CITRATE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PIRACETAM; PROGABIDE; RILUZOLE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

CEREBRAL PALSY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ELECTROENCEPHALOGRAM; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; REVIEW; SPASTICITY; TREATMENT INDICATION;

EID: 0036630396     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0021-75572002000700008     Document Type: Review

References (39)

1. Encefalopatia crônica na infância (paralisia cerebral)
2. Province-based study of neurologic disability among survivors weighing 500 through 1249 grams at birth
3. Encefalopatia crônica da infância ou paralisia cerebral
4. Epidemiology of cerebral palsy
5. The changing panorama of cerebral palsy in Sweden
6. Prevalence of and risk factors for cerebral palsy in a total population cohort of low-birthweight (<2000 g) infants
7. Pessoas portadoras de deficiência. A realidade brasileira
8. The effects of intrauterine asphyxia on the fullterm neonate
9. Mortality and morbidity after intrapartum asphyxa in the preterm fetus
10. Prenatal and perinatal factors in the etiology of cerebral palsy
11. Paralisia cerebral: Estudo de 100 casos
12. Neuropathophysiology of movement disorders in cerebral palsy
13. Effect of vitamin D and calcium on bone mineral density in children with CP and epilepsy in full-time care
14. Outcome after ischemia in the developing sheep brain: An electroencephalographic and histological study
15. Cerebral edema and perinatal hypoxic-ischemic (H-1) brain damage
16. Factors associated with motor and cognitive deficits in children after intrapartum fetal hypoxia
17. Paralisia cerebral
18. Quantifying the effects of interventions for movement disorders resulting from cerebral palsy
19. Methods of rehabilitation in children with neuromuscular disorders
20. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments
21. A controlled pharmacoki netic evaluation of tizanidine and baclofen at steady state
22. Tizanidine treatment of spasticity: A meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam
23. Tizanidine in the management of spasticity and musculoskeletal complaints in the palliative care population
24. Intrathecal baclofen in cerebral palsy movement disorders
25. Intrathecal baclofen pump use for spasticity: A clinical survey
26. Intrathecal baclofen withdrawal simulating neuroepileptic malignant syndrome in a child with cerebral palsy
27. Drugs used to treat spasticity
28. The effect of tiagabine on spasticity in children with intractable epilepsy: A pilot study
29. Neuromuscular blockade in the management of cerebral palsy
30. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy
31. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy
32. Pharmacological interventions for spasticity following spinal cord injury
33. Optimized therapy of spastic syndrome by combination intrathecal baclofen with botulinum toxin
34. Aspectos da relaçâo médico-paciente em neuropediatria